Sfoglia per Autore
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE
2019-01-01 Mancuso, G.; Lanzillotta, M.; Campochiaro, C.; Ramirez, G. A.; Bozzolo, E. P.; Dagna, L.; DELLA TORRE, E
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE
2019-01-01 DELLA TORRE, E; E., Rigamonti1; C., Perugino2; S., Baghai Sain1; L., Rovati1; Lanzillotta1, M.; Stone2, J. H.; Manfredi1, A. A.; S., Pillai2
IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018)
2019-01-01 Lanzillotta, Marco; DELLA TORRE, E; Corrado, Campochiaro; Enrica, Bozzolo; Dagna, Lorenzo
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE
2019-01-01 Corrado, Campochiaro; DELLA TORRE, E; Lanzillotta, Marco; Enrica, Bozzolo; Elena, Baldissera; Dagna, Lorenzo
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease
2019-01-01 DELLA TORRE, E; Elena, Rigamonti; Cory, Perugino; Simona, Baghai Sain; Sun, Na; Naoki, Kaneko; Takashi, Maehara; Lucrezia Rovati, ; Ponzoni, Maurilio; Raffaella, Milani; Lanzillotta, Marco; Vinay Mahajan, ; Hamid, Mattoo; Ivan, Molineris; Vikram, Deshpande; John, H Stone; Falconi, Massimo; Manfredi, Angelo A.; Shiv, Pillai
Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease
2019-01-01 Lanzillotta, Marco; Della-Torre, Emanuel; Milani, Raffaella; Bozzolo, Enrica; Bozzalla-Cassione, Emanuele; Rovati, Lucrezia; Arcidiacono, Paolo Giorgio; Partelli, Stefano; Falconi, Massimo; Ciceri, Fabio; Dagna, Lorenzo
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease
2019-01-01 DELLA TORRE, E; Elena, Rigamonti1; Simona Baghai, Sain3; Lanzillotta, Marco; Cory, Perugino2; John, Stone2; Falconi, Massimo; Shiv, Pillai2; Angelo, Manfredi1
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis
2019-01-01 Rovati, L.; Lanzillotta, M.; Bozzolo, E.; Arcidiacono, P. G.; Falconi, M.; Dagna, L.; Della-Torre, E.; DELLA TORRE, Emanuel
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE
2020-01-01 DELLA TORRE, E; Rovati, L.; Monno, A.; Maehara, T.; Kaneko, N.; Lanzillotta, M.; Pedica, F.; Doglioni, C.; Pillai, S.; Manfredi, A.
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease.
2020-01-01 DELLA TORRE, E; Lanzillotta, M; Yacoub, Mr.
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19
2020-01-01 Spagnuolo, V.; Guffanti, M.; Galli, L.; Poli, A.; Querini, P. R.; Ripa, M.; Clementi, M.; Scarpellini, P.; Lazzarin, A.; Tresoldi, M.; Dagna, L.; Zangrillo, A.; Ciceri, F.; Castagna, A.; Andolina, A.; Redaelli, M. B.; Baldissera, E.; Bigai, G.; Bigoloni, A.; Boffini, N.; Borio, G.; Bossolasco, S.; Bruzzesi, E.; Calabro, M. G.; Calvisi, S.; Campochiaro, C.; Canetti, D.; Canti, V.; Castellani, J.; Castiglioni, B.; Cavalli, G.; Cavallo, L.; Cernuschi, M.; Chiurlo, M.; Cilla, M.; Cinel, E.; Cinque, P.; Conte, C.; Da Prat, V.; Danise, A.; De Lorenzo, R.; De Luca, G.; Dell'Acqua, A.; Dell'Acqua, R.; Torre, E. D.; Torre, L. D.; Di Terlizzi, G.; Dumea, I.; Farolfi, F.; Ferrante, M.; Frangi, C.; Fumagalli, L.; Gallina, G.; Germinario, B.; Gianotti, N.; Hasson, H.; Lalla, F.; Landoni, G.; Lanzillotta, M.; Voti, R. L.; Mastrangelo, A.; Messina, E.; Moizo, E.; Montagna, M.; Monti, G.; Morsica, G.; Muccini, C.; Nozza, S.; Oltolini, C.; Pascali, M.; Patrizi, A.; Pieri, M.; Prestifilippo, D.; Ramirez, G.; Ranzenigo, M.; Sapienza, J.; Sartorelli, S.; Seghi, F.; Tambussi, G.; Din, C. T.; Tomelleri, A.; Turi, S.; Uberti-Foppa, C.; Vinci, C.
Urgent manifestations of immunoglobulin G4-related disease
2020-01-01 Della-Torre, E.; Mancuso, G.; Lanzillotta, M.; Ramirez, G. A.; Arcidiacono, P. G.; Capurso, G.; Falconi, M.; Dagna, L.
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
2020-01-01 Wallace, Zs; Naden, Rp; Chari, S; Choi, Hk; DELLA TORRE, E; Dicaire, Jf; Hart, Pa; Inoue, D; Kawano, M; Khosroshahi, A; Lanzillotta, M; Okazaki, K; Perugino, Ca; Sharma, A; Saeki, T; Schleinitz, N; Takahashi, N; Umehara, H; Zen, Y; Stone, Jh; Members of the ACR/EULAR IgG4-RD Classification Criteria Working, Group.
CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES
2020-01-01 Lanzillotta, M.; DELLA TORRE, E; Campochiaro, C.; Mancuso, G.; Dagna, L.
IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES
2020-01-01 Mancuso, G.; DELLA TORRE, E; Lanzillotta, M.; Ramirez, G. A.; Dagna, L.
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
2020-01-01 Wallace, Zs; Naden, Rp; Chari, S; Choi, H; DELLA TORRE, E; Dicaire, Jf; Hart, Pa; Inoue, D; Kawano, M; Khosroshahi, A; Kubota, K; Lanzillotta, M; Okazaki, K; Perugino, Ca; Sharma, A; Saeki, T; Sekiguchi, H; Schleinitz, N; Stone, Jr; Takahashi, N; Umehara, H; Webster, G; Zen, Y; Stone, Jh; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working, Group.
Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease
2020-01-01 Campochiaro, C.; Della-Torre, E.; Lanzillotta, M.; Bozzolo, E.; Baldissera, E.; Milani, R.; Arcidiacono, P. G.; Crippa, S.; Falconi, M.; Dagna, L.
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase
2020-01-01 Oltolini, Chiara; Guidetti, Anna; Ripa, Marco; Castiglioni, Barbara; Tassan Din, Chiara; Mastaglio, Sara; Canetti, Diana; Monti, Giacomo; Andolina, Andrea; Molinari, Chiara; Poloniato, Antonella; Mastrangelo, Andrea; Ferrante, Marica; Lanzillotta, Marco; Scarpellini, Paolo; Castagna, Antonella; Corradini, Paolo; Ciceri, Fabio
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study
2020-01-01 Della-Torre, E.; Campochiaro, C.; Cavalli, G.; De Luca, G.; Napolitano, A.; La Marca, S.; Boffini, N.; Da Prat, V.; Di Terlizzi, G.; Lanzillotta, M.; Rovere Querini, P.; Ruggeri, A.; Landoni, G.; Tresoldi, M.; Ciceri, F.; Zangrillo, A.; De Cobelli, F.; Dagna, L.
Advances in the diagnosis and management of IgG4 related disease.
2020-01-01 Lanzillotta, M; Mancuso, G; DELLA TORRE, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE | 1-gen-2019 | Mancuso, G.; Lanzillotta, M.; Campochiaro, C.; Ramirez, G. A.; Bozzolo, E. P.; Dagna, L.; DELLA TORRE, E | |
| B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE | 1-gen-2019 | DELLA TORRE, E; E., Rigamonti1; C., Perugino2; S., Baghai Sain1; L., Rovati1; Lanzillotta1, M.; Stone2, J. H.; Manfredi1, A. A.; S., Pillai2 | |
| IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018) | 1-gen-2019 | Lanzillotta, Marco; DELLA TORRE, E; Corrado, Campochiaro; Enrica, Bozzolo; Dagna, Lorenzo | |
| EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE | 1-gen-2019 | Corrado, Campochiaro; DELLA TORRE, E; Lanzillotta, Marco; Enrica, Bozzolo; Elena, Baldissera; Dagna, Lorenzo | |
| B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease | 1-gen-2019 | DELLA TORRE, E; Elena, Rigamonti; Cory, Perugino; Simona, Baghai Sain; Sun, Na; Naoki, Kaneko; Takashi, Maehara; Lucrezia Rovati, ; Ponzoni, Maurilio; Raffaella, Milani; Lanzillotta, Marco; Vinay Mahajan, ; Hamid, Mattoo; Ivan, Molineris; Vikram, Deshpande; John, H Stone; Falconi, Massimo; Manfredi, Angelo A.; Shiv, Pillai | |
| Effects of glucocorticoids on B-cell subpopulations in patients with IgG4-related disease | 1-gen-2019 | Lanzillotta, Marco; Della-Torre, Emanuel; Milani, Raffaella; Bozzolo, Enrica; Bozzalla-Cassione, Emanuele; Rovati, Lucrezia; Arcidiacono, Paolo Giorgio; Partelli, Stefano; Falconi, Massimo; Ciceri, Fabio; Dagna, Lorenzo | |
| B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease | 1-gen-2019 | DELLA TORRE, E; Elena, Rigamonti1; Simona Baghai, Sain3; Lanzillotta, Marco; Cory, Perugino2; John, Stone2; Falconi, Massimo; Shiv, Pillai2; Angelo, Manfredi1 | |
| Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis | 1-gen-2019 | Rovati, L.; Lanzillotta, M.; Bozzolo, E.; Arcidiacono, P. G.; Falconi, M.; Dagna, L.; Della-Torre, E.; DELLA TORRE, Emanuel | |
| MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE | 1-gen-2020 | DELLA TORRE, E; Rovati, L.; Monno, A.; Maehara, T.; Kaneko, N.; Lanzillotta, M.; Pedica, F.; Doglioni, C.; Pillai, S.; Manfredi, A. | |
| Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. | 1-gen-2020 | DELLA TORRE, E; Lanzillotta, M; Yacoub, Mr. | |
| Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 | 1-gen-2020 | Spagnuolo, V.; Guffanti, M.; Galli, L.; Poli, A.; Querini, P. R.; Ripa, M.; Clementi, M.; Scarpellini, P.; Lazzarin, A.; Tresoldi, M.; Dagna, L.; Zangrillo, A.; Ciceri, F.; Castagna, A.; Andolina, A.; Redaelli, M. B.; Baldissera, E.; Bigai, G.; Bigoloni, A.; Boffini, N.; Borio, G.; Bossolasco, S.; Bruzzesi, E.; Calabro, M. G.; Calvisi, S.; Campochiaro, C.; Canetti, D.; Canti, V.; Castellani, J.; Castiglioni, B.; Cavalli, G.; Cavallo, L.; Cernuschi, M.; Chiurlo, M.; Cilla, M.; Cinel, E.; Cinque, P.; Conte, C.; Da Prat, V.; Danise, A.; De Lorenzo, R.; De Luca, G.; Dell'Acqua, A.; Dell'Acqua, R.; Torre, E. D.; Torre, L. D.; Di Terlizzi, G.; Dumea, I.; Farolfi, F.; Ferrante, M.; Frangi, C.; Fumagalli, L.; Gallina, G.; Germinario, B.; Gianotti, N.; Hasson, H.; Lalla, F.; Landoni, G.; Lanzillotta, M.; Voti, R. L.; Mastrangelo, A.; Messina, E.; Moizo, E.; Montagna, M.; Monti, G.; Morsica, G.; Muccini, C.; Nozza, S.; Oltolini, C.; Pascali, M.; Patrizi, A.; Pieri, M.; Prestifilippo, D.; Ramirez, G.; Ranzenigo, M.; Sapienza, J.; Sartorelli, S.; Seghi, F.; Tambussi, G.; Din, C. T.; Tomelleri, A.; Turi, S.; Uberti-Foppa, C.; Vinci, C. | |
| Urgent manifestations of immunoglobulin G4-related disease | 1-gen-2020 | Della-Torre, E.; Mancuso, G.; Lanzillotta, M.; Ramirez, G. A.; Arcidiacono, P. G.; Capurso, G.; Falconi, M.; Dagna, L. | |
| The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. | 1-gen-2020 | Wallace, Zs; Naden, Rp; Chari, S; Choi, Hk; DELLA TORRE, E; Dicaire, Jf; Hart, Pa; Inoue, D; Kawano, M; Khosroshahi, A; Lanzillotta, M; Okazaki, K; Perugino, Ca; Sharma, A; Saeki, T; Schleinitz, N; Takahashi, N; Umehara, H; Zen, Y; Stone, Jh; Members of the ACR/EULAR IgG4-RD Classification Criteria Working, Group. | |
| CLINICAL PHENOTYPES OF IGG4- RELATED DISEASE REFLECT DIFFERENCES IN EPIDEMIOLOGICAL FEATURES, SEROLOGICAL FINDINGS,AND PROGNOSTIC OUTCOMES | 1-gen-2020 | Lanzillotta, M.; DELLA TORRE, E; Campochiaro, C.; Mancuso, G.; Dagna, L. | |
| IgG4-RELATED DISEASE PRESENTATION REQUIRES ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES | 1-gen-2020 | Mancuso, G.; DELLA TORRE, E; Lanzillotta, M.; Ramirez, G. A.; Dagna, L. | |
| The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. | 1-gen-2020 | Wallace, Zs; Naden, Rp; Chari, S; Choi, H; DELLA TORRE, E; Dicaire, Jf; Hart, Pa; Inoue, D; Kawano, M; Khosroshahi, A; Kubota, K; Lanzillotta, M; Okazaki, K; Perugino, Ca; Sharma, A; Saeki, T; Sekiguchi, H; Schleinitz, N; Stone, Jr; Takahashi, N; Umehara, H; Webster, G; Zen, Y; Stone, Jh; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working, Group. | |
| Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease | 1-gen-2020 | Campochiaro, C.; Della-Torre, E.; Lanzillotta, M.; Bozzolo, E.; Baldissera, E.; Milani, R.; Arcidiacono, P. G.; Crippa, S.; Falconi, M.; Dagna, L. | |
| Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase | 1-gen-2020 | Oltolini, Chiara; Guidetti, Anna; Ripa, Marco; Castiglioni, Barbara; Tassan Din, Chiara; Mastaglio, Sara; Canetti, Diana; Monti, Giacomo; Andolina, Andrea; Molinari, Chiara; Poloniato, Antonella; Mastrangelo, Andrea; Ferrante, Marica; Lanzillotta, Marco; Scarpellini, Paolo; Castagna, Antonella; Corradini, Paolo; Ciceri, Fabio | |
| Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study | 1-gen-2020 | Della-Torre, E.; Campochiaro, C.; Cavalli, G.; De Luca, G.; Napolitano, A.; La Marca, S.; Boffini, N.; Da Prat, V.; Di Terlizzi, G.; Lanzillotta, M.; Rovere Querini, P.; Ruggeri, A.; Landoni, G.; Tresoldi, M.; Ciceri, F.; Zangrillo, A.; De Cobelli, F.; Dagna, L. | |
| Advances in the diagnosis and management of IgG4 related disease. | 1-gen-2020 | Lanzillotta, M; Mancuso, G; DELLA TORRE, E |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile